Acquirer · Corporate
argenx
1$550m$550m0
Photo: Goldmund100 / Wikimedia Commons, CC BY-SA 3.0argenx agrees to buy Unnatural Products for $550 million upfront to add oral peptide drug discovery
The two companies had worked together for more than two years, and argenx already owned part of the Santa Cruz biotech. The full price could reach about $1.15 billion if development and regulatory milestones are met.
$550m$77mSeries BCorporate
Latest in argenx
All argenx exitsOpen tracker →
argenx → Unnatural Products$550m$250m–1bn